Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone ER vs oxycodone ER for chronic moderate to severe pain
ChiCTR2500105273Phase 4Not yet recruiting
- Sponsor
- Shenzhen Nanshan People's Hospital
- Start
- Jul 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic pain comparing Oxycodone ER arm with Hydromorphone ER arm (2 arms). Primary endpoints: Proportion of patients with effective pain relief and Adverse event incidence rate. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
hydromorphoneoxycodone
03
Conditions
chronic pain
Beyond the preview
Go deeper on ChiCTR2500105273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105273.